We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
MGE Energy Inc
MGEE
$3.06B
| $934K | ﹤0.01% |
12,004
+4,208
| +54% | +$336K |
|
1452
Amneal Pharmaceuticals
AMRX
$5.46B
| $930K | ﹤0.01% |
292,337
+55,339
| +23% | +$200K |
|
|
FOLD
1453
DELISTED
Amicus Therapeutics
FOLD
| $929K | ﹤0.01% |
86,478
-2,413
| -3% | -$19.9K |
|
|
WBT
1454
DELISTED
Welbilt, Inc.
WBT
| $928K | ﹤0.01% |
38,987
-1,056
| -3% | -$24.9K |
|
|
GOLD
1455
Gold.com Inc
GOLD
$1.26B
| $924K | ﹤0.01% |
28,652
+14,394
| +101% | +$517K |
|
1456
Americold
COLD
$4.13B
| $921K | ﹤0.01% |
30,887
+1,796
| +6% | +$49.9K |
|
1457
Snap
SNAP
$9.32B
| $919K | ﹤0.01% |
70,499
+44,098
| +167% | +$1.01M |
|
1458
Aptiv
APTV
$10.3B
| $916K | ﹤0.01% |
10,498
-158,596
| -94% | -$16.2M |
|
1459
AerSale
ASLE
$273M
| $913K | ﹤0.01% |
+62,892
| New | +$913K |
|
1460
FMC
FMC
$1.3B
| $912K | ﹤0.01% |
8,588
+310
| +4% | +$37.9K |
|
|
DBD
1461
DELISTED
Diebold Nixdorf Incorporated
DBD
| $912K | ﹤0.01% |
401,804
+290,594
| +261% | +$1.08M |
|
|
SPLK
1462
DELISTED
Splunk Inc
SPLK
| $911K | ﹤0.01% |
10,425
+4,064
| +64% | +$447K |
|
1463
Exponent
EXPO
$3.25B
| $906K | ﹤0.01% |
9,900
-3,919
| -28% | -$369K |
|
1464
PC Connection
CNXN
$2.04B
| $905K | ﹤0.01% |
20,544
+4,865
| +31% | +$231K |
|
1465
Modine Manufacturing
MOD
$10.5B
| $905K | ﹤0.01% |
85,950
+2,139
| +3% | +$20.2K |
|
|
NVEE
1466
DELISTED
NV5 Global
NVEE
| $905K | ﹤0.01% |
31,012
-9,060
| -23% | -$272K |
|
1467
Dave & Buster's
PLAY
$349M
| $900K | ﹤0.01% |
27,442
+11,762
| +75% | +$472K |
|
|
MANT
1468
DELISTED
Mantech International Corp
MANT
| $899K | ﹤0.01% |
+9,420
| New | +$842K |
|
1469
Talos Energy
TALO
$2.6B
| $893K | ﹤0.01% |
57,719
+35,257
| +157% | +$686K |
|
1470
Koppers
KOP
$869M
| $889K | ﹤0.01% |
+39,256
| New | +$995K |
|
1471
Herc Holdings
HRI
$5.72B
| $888K | ﹤0.01% |
9,849
-184
| -2% | -$22.1K |
|
|
CLDT
1472
Chatham Lodging
CLDT
$580M
| $884K | ﹤0.01% |
84,626
-6,725
| -7% | -$84.6K |
|
1473
iRadimed
IRMD
$1.14B
| $884K | ﹤0.01% |
26,034
+21,181
| +436% | +$759K |
|
|
SPTN
1474
DELISTED
SpartanNash
SPTN
| $880K | ﹤0.01% |
29,159
+4,397
| +18% | +$146K |
|
|
EGLE
1475
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $879K | ﹤0.01% |
16,939
+65
| +0.4% | +$4.16K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.